Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group (Q28265868)
scientific article
Language:
Current Data About Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group
(P31) (Q13442814)

(P304) 701-8

(P407) (Q1860)

(P433) 3

(P478) 50

(P577) +1998-03-00T00:00:00Z

(P921) (Q12131)

(Q8277)

(P1433) (Q1161692)

(P1476) "Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group" (language: en)

(P2093) K P Johnson
(P1545) 1

B R Brooks
(P1545) 2

J A Cohen
(P1545) 3

C C Ford
(P1545) 4

J Goldstein
(P1545) 5

R P Lisak
(P1545) 6

L W Myers
(P1545) 7

H S Panitch
(P1545) 8

J W Rose
(P1545) 9

R B Schiffer
(P1545) 10

T Vollmer
(P1545) 11

L P Weiner
(P1545) 12

J S Wolinsky
(P1545) 13

other details
description scientific article

External Links
(P356) 10.1212/WNL.50.3.701
(P698) 9521260
(P3181) 4823765